Visit Abgent at booth 919 at the upcoming NIH Research Festival
Sep 17, 2015
        
		Visit Abgent at the NIH Research Festival
	
		Booth 919
	
		September 17-18, on the NIH Campus outside building 10 in Bethesda

	Abgent Custom Services
					  ![]()  | 
				
					Antibody development
					 
						Over 20,000 projects completed, including: modification-state, idiotypic, GPCR, and phage display antibodies. 
				 | 
			
					  ![]()  | 
				
					Peptide Synthesis
					 
						Routine and challenging peptides, fast turn around time, high yield quality products at specified purity level. 
				 | 
			
					  ![]()  | 
				
					Validation services
					 
						Western Blot (WB), Immunofluorescence (IF), Immunohistochemistry (IHC), Flow Cytometry (FC), and additional validation services. 
				 | 
			
	Abgent Research Areas of Focus
Events
            


                                
                                
                                

                                        
                                        
                                        
                                        
                                        
Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.
